Cited by 342Attention Deficit Hyperactivity DisorderPharmaceutical studies and practicesDevelopmental and Educational Neuropsychology

The DOI matches its Crossref record; 26 of the 26 references it cites were found in a registry or an index.

Pharmacologic Treatment of Attention Deficit–Hyperactivity Disorder

Cortese, Samuele·2020·New England Journal of Medicine

DOI 10.1056/nejmra1917069

Open this paper in CoChat — free account

Abstract

Amphetamines and methylphenidate and, less often, nonstimulants (atomoxetine, clonidine, and guanfacine) are used to treat ADHD. Inattentiveness and restlessness are improved more than quality-of-life measures in short-term trials.

Integrity signals

Registry

Crossref · 10.1056/nejmra1917069

Cites

26 of 26 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

ADHD prevalence estimates across three decades: an updated systematic review and meta-regression analysis
Polanczyk, G. V., Willcutt, E. G., Salum, G. A., Kieling, C., & Rohde, L. A. (2014) · International Journal of Epidemiology · doi:10.1093/ije/dyt261 · Cited by 1,822
Clinical Practice Guideline for the Diagnosis, Evaluation, and Treatment of Attention-Deficit/Hyperactivity Disorder in Children and Adolescents
Wolraich, M. L., Hagan, J. F., Allan, C., Chan, E., Davison, D., Earls, M., Evans, S. W., Flinn, S. K., Froehlich, T., Frost, J., et al. (2019) · Pediatrics · doi:10.1542/peds.2019-2528 · Cited by 1,562
Attention-deficit/hyperactivity disorder
Faraone, S. V., Asherson, P., Banaschewski, T., Biederman, J., Buitelaar, J. K., Ramos-Quiroga, J. A., Rohde, L. A., Sonuga-Barke, E. J. S., Tannock, R., & Franke, B. (2015) · Nature Reviews Disease Primers · doi:10.1038/nrdp.2015.20 · Cited by 1,479
Comparative efficacy and tolerability of medications for attention-deficit hyperactivity disorder in children, adolescents, and adults: a systematic review and network meta-analysis
Cortese, S., Adamo, N., Del Giovane, C., Mohr-Jensen, C., Hayes, A. J., Carucci, S., Atkinson, L. Z., Tessari, L., Banaschewski, T., Coghill, D., et al. (2018) · The Lancet Psychiatry · doi:10.1016/s2215-0366(18)30269-4 · Cited by 1,402
Self-citation
Meta-analysis of Functional Magnetic Resonance Imaging Studies of Inhibition and Attention in Attention-deficit/Hyperactivity Disorder: Exploring Task-Specific, Stimulant Medication, and Age Effects
Hart, H., Radua, J., Nakao, T., Mataix-Cols, D., & Rubia, K. (2013) · JAMA Psychiatry · doi:10.1001/jamapsychiatry.2013.277 · Cited by 764
Brain imaging of the cortex in ADHD: a coordinated analysis of large-scale clinical and population-based samples
Hoogman, M., Muetzel, R., Guimaraes, J. P., Shumskaya, E., Mennes, M., Zwiers, M. P., Jahanshad, N., Sudre, G., Wolfers, T., Earl, E. A., et al. (2019) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2019.18091033 · Cited by 467
Putting the efficacy of psychiatric and general medicine medication into perspective: review of meta-analyses
Leucht, S., Hierl, S., Kissling, W., Dold, M., & Davis, J. M. (2012) · British Journal of Psychiatry · doi:10.1192/bjp.bp.111.096594 · Cited by 451
Practitioner Review: Current best practice in the management of adverse events during treatment with ADHD medications in children and adolescents
Cortese, S., Holtmann, M., Banaschewski, T., Buitelaar, J., Coghill, D., Danckaerts, M., Dittmann, R. W., Graham, J., Taylor, E., Sergeant, J., et al. (2013) · Journal of Child Psychology and Psychiatry · doi:10.1111/jcpp.12036 · Cited by 336
Self-citation
Effects of stimulants on brain function in attention-deficit/hyperactivity disorder: a systematic review and meta-analysis
Rubia, K., Alegria, A. A., Cubillo, A. I., Smith, A. B., Brammer, M. J., & Radua, J. (2014) · Biological Psychiatry · doi:10.1016/j.biopsych.2013.10.016 · Cited by 315
Trends in attention-deficit hyperactivity disorder medication use: a retrospective observational study using population-based databases.
Raman, S. R., Man, K. K. C., Bahmanyar, S., Bérard, A., Bilder, S., Boukhris, T., Bushnell, G., Crystal, S., Furu, K., KaoYang, Y.-H., et al. (2018) · Lancet psychiatry · doi:10.1016/s2215-0366(18)30293-1 · Cited by 285

Show all 26 references

Research works printed but not linked: 2

Gajria K, Lu M, Sikirica V, et al. Adherence, persistence, and medication discontinuation in patients with attention-deficit/hyperactivity disorder — a systematic literature review. Neuropsychiatr Dis Treat 2014;10:1543-1569.25187718
Faraone SV, Biederman J, Morley CP, Spencer TJ. Effect of stimulants on height and weight: a review of the literature. J Am Acad Child Adolesc Psychiatry 2008;47:994-1009.18580502

Sorted by citations

Items 301–341 of 341

Ocular structural parameters in children with attention-deficit/hyperactivity disorder: a case-control study of drug-naïve and methylphenidate-treated patients
Yener, N. P., Uzun, M., & Demirci, H. (2026) · BMC Ophthalmology · doi:10.1186/s12886-026-04713-z
Stimulant shortage in children with ADHD: greater vulnerability among those with comorbidity
Acehan, T., Bağlıcakoğlu, E. G., Aliyev, E. S. A., Devecioğlu, H. B., Canlı, M. A., Çelik, Y. S., Efe, A., & Öztürk, Y. (2026) · BMC Psychiatry · doi:10.1186/s12888-026-07958-6
ADHD in children, adolescents, and adults: incidence, prevalence, and treatment. An analysis of routine health insurance data
Betzler, F., Knop, J., Grönig, M., Timpel, P., Višković, V., & Schöttle, D. (2026) · Deutsches Ärzteblatt international · doi:10.3238/arztebl.m2026.0032 · Cited by 1
The effects of methylphenidate and atomoxetine on epigenetic DNA modifiers in an in vitro model of human peripheral blood mononuclear cells
Pulk, K., Schotter, G., Anier, K., & Kalda, A. (2026) · Epigenetics Reports · doi:10.1080/28361512.2026.2650336
Randomised controlled trial on the efficacy of adding cognitive remediation therapy to methylphenidate in adult patients with attention deficit hyperactivity disorder and addictive disorders (META): CRT in ADHD and addiction – META study protocol
Cabelguen, C., Challet‐Bouju, G., Thiabaud, E., Donnio, Y., Lefebvre, L., Hardouin, J.-B., & Grall‐Bronnec, M. (2026) · BMJ Open · doi:10.1136/bmjopen-2025-111698
d -Amphetamine Transdermal System in Treatment of Children and Adolescents With ADHD: SKAMP Subscale Analysis and Subgroup Analysis from a Pivotal Trial
Cutler, A. J., Komaroff, M., Castelli, M., Meeves, S. G., & Khan, M. (2026) · Journal of Child and Adolescent Psychopharmacology · doi:10.1177/10445463261434530
Cooccurrence entre le TDAH chez l'adulte et les addictions comportementales : étude en populations non-clinique et clinique de la prévalence et des facteurs psychopathologiques associés
Archi, S. E. (2022) · theses.fr (ABES) · doi:10.70675/ae7c8507z68dcz4883z96e8z10ad27a2bc6b
Diagnosis and Management of Adult Attention-Deficit/Hyperactivity Disorder
Worringer, E., & Caçoilo, M. (2026) · Primary Care Clinics in Office Practice · doi:10.1016/j.pop.2026.01.006
Longitudinal and Seasonal Trends in Reimbursed and Non‐Reimbursed Methylphenidate Dispense and Its Most Common Alternatives in Belgium
Wichelen, N. V., Boogaerts, T., Raeime, A., Ferreira, L. S., Gys, C., Covaci, A., van Nuijs, A. L. N., & Loof, H. D. (2026) · Pharmacoepidemiology and Drug Safety · doi:10.1002/pds.70380
Stimulant Medications and Bone Health
Swanson, C. M., Wolfe, J. H., & Calarge, C. A. (2026) · Current Osteoporosis Reports · doi:10.1007/s11914-026-00965-2
Academic Performance Pressure and Methylphenidate Consumption: Insights From Wastewater‐Based Epidemiology
Wichelen, N. V., Boogaerts, T., Hal, G. V., Fransén, E., Gys, C., Covaci, A., & van Nuijs, A. L. N. (2026) · Drug Testing and Analysis · doi:10.1002/dta.70088
How much is enough in ADHD pharmacotherapy?
Caye, A. (2026) · The Lancet Psychiatry · doi:10.1016/s2215-0366(26)00122-7
Cross-training digital therapeutics for pediatric ADHD: study protocol for a randomized controlled trial
Zhao, X., Cai, Y., Zhang, X., Xu, T., Qian, Y., Hao, W., Wang, Y., Yuan, J., Cai, T., Zhou, L., et al. (2026) · Trials · doi:10.1186/s13063-026-09775-4
The Evolving Pharmacological Landscape for Paediatric and Adult ADHD
Veronesi, G. F., Tarantino, F., Pirolo, D., & Cortese, S. (2026) · CNS Drugs · doi:10.1007/s40263-026-01299-4
Self-citation
Pharmacovigilance for Health Management: A National Profile of Methylphenidate Adverse Events in Thailand Using National Databases
Sukthas, S., Soontorntham, P., & Saokaew, S. (2026) · Journal of Health Research · doi:10.56808/2586-940x.1199
Exploring adolescents’ and parents’ experiences of pharmacological and non-pharmacological treatment in ADHD: a qualitative study
Karimi, M., Ghasemzadeh, S., Ghasemzadeh, P., صالحی, ک., & Fami, F. S. (2026) · BMC Psychiatry · doi:10.1186/s12888-026-08293-6
Physalis angulata Leaf Extract Attenuates H2O2-Induced Neurotoxicity in Zebrafish Through Metabolomic Evidence of Antioxidant Pathway Restoration
Sulistio, F. A., James, R. J., Ramli, S., Mulyadi, C. A., Halim, H., Vin, M., Saputri, F. C., Hamdani, I. Y., Mubarok, S., Naila, A. H., et al. (2026) · Antioxidants · doi:10.3390/antiox15060758
Tool for Converting ADHD Rating Scales Scores Based on Individual Participant Data from 53 Randomized Controlled Trials of ADHD Medications
Christogiannis, C., Garcia‐Argibay, M., Tomlinson, A., Roy, S., Farhat, L. C., Veronesi, G. F., Parlatini, V., Bellato, A., Gosling, C. J., Mavridis, D., et al. (2026) · Journal of Child and Adolescent Psychopharmacology · doi:10.1177/10445463261461541
Self-citation
ADHD medication discontinuation and non-adherence: a Norwegian population-based register study
Garcia‐Argibay, M., Hofstad, T., Bjelland, I., Cortese, S., & Mykletun, A. (2026) · BMJ Mental Health · doi:10.1136/bmjment-2026-302649
Self-citation
Reassessing ADHD Management: Integrating Gut Microbiome Insights and Herbal Nutritional Strategies
Elkalla, W. S., Salah, A. N., Mahmoud, N. A., AbdelRazek, M. M. M., Kotb, S. S., Elshami, N. H., AlFarsi, K., Waseem, A. M., Bogari, H. A., Malatani, R. T., et al. (2026) · Bratislavské lekárske listy/Bratislava medical journal · doi:10.1007/s44411-026-00712-0
Trends in methylphenidate dispensing and regional inequalities among children and adolescents in France around the 2021 prescription reform: a repeated cross-sectional ecological analysis of national data (2014–2024)
Guez, E., van der Waerden, J. E. B., Cohen, D., & Benarous, X. (2026) · BMC Public Health · doi:10.1186/s12889-026-28213-3
Demographic and Clinical Predictors of Attention-deficit/Hyperactivity Disorder Treatment Among Youth and Adults With Co-occurring Substance Use Disorder
Baweja, R. K., Waschbusch, D. A., Baweja, R., Sarkar, N., Singh, B., Molina, B. S. G., Wilens, T. E., & Waxmonsky, J. G. (2026) · Journal of Addiction Medicine · doi:10.1097/adm.0000000000001734
Visual Evoked Potentials and Clinical Progress in ADHD: A Three-Month Follow-Up Study
Acehan, T., Yurtdaş, M., & Yoldaş, T. K. (2026) · Ankara Üniversitesi Tıp Fakültesi Mecmuası · doi:10.65092/autfm.1909672
A Descriptive Review of Nordic Clinical Practice Guidelines for Pediatric ADHD: Evaluating the Evidence Base for Methylphenidate
Ruokoniemi, P. T. (2026) · Scandinavian Journal of Child and Adolescent Psychiatry and Psychology · doi:10.2478/sjcapp-2026-0006
Exercise combined with pediatric Tuina and auricular acupressure for children with attention-deficit/hyperactivity disorder: a randomized controlled trial
Xiong, M., Jiang, S., Sun, Y., Cong, X., Zhao, N., & Wu, F. (2026) · Frontiers in Medicine · doi:10.3389/fmed.2026.1880554
Pharmacokinetics at Different Application Sites and Dermal Safety Analysis of Dextroamphetamine Transdermal System (d-ATS) in Healthy Adults and Patients with ADHD
Mattingly, G. W., Haj-Ibrahim, H., Komaroff, M., Meeves, S. G., Khan, M., & Castelli, M. (2026) · Advances in Therapy · doi:10.1007/s12325-026-03728-8
Medication use, social determinants of health, and latent trajectories of functional outcomes in children with attention-deficit/hyperactivity disorder
Fletcher, M., Pan, W., Duquette, P. J., Dew, R. E., & Reuter‐Rice, K. (2026) · PLoS ONE · doi:10.1371/journal.pone.0350337
Real-world ADHD pharmacological treatment patterns and their association with negative clinical outcomes in youth with comorbid autism: a Swedish population-based study
Garcia‐Argibay, M., Kuja‐Halkola, R., D'Onofrio, B. M., Lichtenstein, P., Chang, Z., Larsson, H., & Cortese, S. (2026) · BMJ Mental Health · doi:10.1136/bmjment-2026-302902
Self-citation
Candidate Clinico-Demographic Predictors or Moderators of Efficacy and Tolerability of Pharmacological Treatment in Attention-Deficit/Hyperactivity Disorder (ADHD): An Analysis of the MED-ADHD Repository of Randomised Controlled Trials
Roy, S., Veronesi, G. F., Mannarini, S., Pirolo, D., Bellato, A., Cortese, S., & Parlatini, V. (2026) · CNS Drugs · doi:10.1007/s40263-026-01323-7
Self-citation
From prediction to decision: prediction-based decision rules and target trial emulation in ADHD
Garcia‐Argibay, M., Faraone, S. V., Chang, Z., Cortese, S., & Larsson, H. (2026) · The Lancet Psychiatry · doi:10.1016/s2215-0366(26)00227-0
Self-citation
Clinical practices in ADHD management across Europe: findings from the ESCAP research academy survey
Young, H., Revet, A., Hagstrøm, J., Ateş, B. Ö., Brænden, A., Grigoriou, M., Jarvers, I., Jederström, M., Jurek, L., Kotsis, K. Τ., et al. (2026) · European Child & Adolescent Psychiatry · doi:10.1007/s00787-026-03161-w
Self-citation
Prevalence, Trends and Patterns of ADHD Medication Use Among Children, Adolescents and Young Adults in Quebec, Canada: A Repeated Cross-Sectional Population-Based Study From 2000 to 2022: Prévalence, tendances et profils d’utilisation des médicaments pour le TDAH chez les enfants, les adolescents et les jeunes adultes au Québec (Canada) : étude populationnelle transversale répétée, 2000-2022
Gignac, M., Fansi, A. K., Lunghi, C., Diallo, F., Rochette, L., Massamba, V. K., Vasiliadis, H., Rahme, E., Cortese, S., & LESAGE, A. D. (2026) · The Canadian Journal of Psychiatry · doi:10.1177/07067437261471748
Self-citation
The association of ADHD and ADHD medication with adherence to pharmacotherapy for type 2 diabetes: a population-based cohort study from seven countries
Zhou, Y., Yao, H., Xie, T., Gillies, M. B., Zhang‐James, Y., Brikell, I., Engeland, A., Gao, L., Semark, B. D., Wimberley, T., et al. (2026) · EClinicalMedicine · doi:10.1016/j.eclinm.2026.104182
County-level variation and trajectories in ADHD medication dispensing among Norwegian children and adolescents, 2005-2022: a nationwide prescription register study
Anker, E., Bendiksen, B., Wergeland, G. J., & Thomsen, P. H. (2026) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2026.1861616
Electroencephalographic Signatures of Methylphenidate in ADHD: A Systematic Review and 10 Recommendations for Future Research
Quinn, D., Earley, C., Scarlat, I.-M., Whelan, R., & McGrath, J. (2026) · Journal of Attention Disorders · doi:10.1177/10870547261483457
Centanafadine and the Expanding Pharmacologic Landscape of ADHD
Baweja, R. K., & Wilens, T. E. (2026) · Journal of Child and Adolescent Psychopharmacology · doi:10.1177/10445463261487758
Age-stratified safety signal mining of ADHD medications in pediatric populations using the FAERS database (2014–2024): a pharmacovigilance study using multi-method disproportionality analysis
Qin, G., & Chen, L. (2026) · Frontiers in Pediatrics · doi:10.3389/fped.2026.1865791
Regulatory reform and adult methylphenidate dispensing in France: a nationwide interrupted time-series study
Saint‐Dizier, C., Therribout, N., Carton, L., Icick, R., Mercier, P., Caron, C., Bubrovszky, M., HAMROUN, A., Génin, M., & Lamer, A. (2026) · BMJ Mental Health · doi:10.1136/bmjment-2026-302693
Effect of Direct and Systemic Atomoxetine Administration on Detrusor Contractility in Mice: Implications for Atomoxetine‐Induced Urinary Retention
Engin, S., & Ferikoğlu, B. S. (2026) · Basic & Clinical Pharmacology & Toxicology · doi:10.1111/bcpt.70310
Investigating Potential Adverse Drug Reactions of Lisdexamfetamine Using Sequence Symmetry Analysis
Jensen, T. L., Thysen, S. M., Jimenez‐Solem, E., Jørgensen, A., Jensen, C. B., Pedersen, H. K., Osler, M., Nielsen, M., & Lund, L. C. (2026) · Basic & Clinical Pharmacology & Toxicology · doi:10.1111/bcpt.70316
Home-based tDCS as an add-on to digital cognitive behavioral therapy application (dCBT app) in adults with ADHD: A sham-controlled randomized pilot study
Kerkel, K., Reißmann, A., Treml, L., Schecklmann, M., Jacob, G. A., Osnabruegge, M., Langguth, B., & Schoisswohl, S. (2026) · Psychiatry Research · doi:10.1016/j.psychres.2026.117515

Authors: Cortese, S.
Affiliations: University of Nottingham (GB)
Corresponding author: Cortese, Samuele
ORCID: Cortese, Samuele
Venue: New England Journal of Medicine
Publisher: Massachusetts Medical Society
Published: 2020-09-10
Volume: 383
Issue: 11
Pages: 1050-1056
ISSN: 0028-4793 (ISSN-L)
1533-4406
DOI: 10.1056/nejmra1917069
OpenAlex: W3084409057
Cited by: 342
References: 26
Citations by year: 2026: 60 · 2025: 43 · 2024: 52 · 2023: 61 · 2022: 65 · 2021: 56 · 2020: 5
FWCI: 7.76
Type: journal article
Language: en
Open access: closed
Locations: New England Journal of Medicine (publishedVersion)
PubMed (publishedVersion)
ePrints Soton (University of Southampton) (acceptedVersion)
Topics: Health Sciences › Medicine › Psychiatry and Mental health › Attention Deficit Hyperactivity Disorder
Health Sciences › Medicine › Pediatrics, Perinatology and Child Health › Pharmaceutical studies and practices
Social Sciences › Psychology › Neuropsychology and Physiological Psychology › Developmental and Educational Neuropsychology
Keywords: attention deficit hyperactivity disorder, pharmacotherapy, amphetamine, methylphenidate, atomoxetine, clonidine, guanfacine, stimulants, non-stimulant medication, inattention, restlessness, quality of life
MeSH terms: Atomoxetine Hydrochloride, Adolescent, Adult, Amphetamines, Attention Deficit Disorder with Hyperactivity, Child, Child, Preschool, Growth, Heart Rate, Humans, Hypertension, Methylphenidate, Patient Dropouts, Polymers, Guanfacine, Treatment Outcome, Practice Guidelines as Topic

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Pharmacologic Treatment of Attention Deficit–Hyperactivity Disorder

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Citations

Cites

Cited by

Related

Metadata

Record

About these checks